Full Length Research Paper
References
|
Adjei GO, Goka BQ, Enweronu-Laryea CC, Rodrigues OP, Renner L, Sulley AM, Alifrangis M, Khalil I, Kurtzhals JA (2014). A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria. Malaria Journal 13(1):369. |
|
|
Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, White NJ (2014). Spread of Artemisinin Resistance in Plasmodium falciparum Malaria. The New England Journal of Medicine 371(5):411-423. |
|
|
Balikagala B, Mita T, Ikeda M, Sakurai M, Yatsushiro S, Takahashi N, Tachibana SI, Auma M, Ntege EH, Ito D, Takashima E, Palacpac NMQ, Egwang TG, Onen JO, Kataoka M, Kimura E, Horii T, Tsuboi T (2017). Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda. Malaria Journal16(1):1-11 |
|
|
Basco LK, Le Bras J (1993). In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene 48(1):120-125. |
|
|
Cheemadan S, Ramadoss R, Bozdech Z (2014). Role of calcium signaling in the transcriptional regulation of the apicoplast genome of plasmodium falciparum. BioMed Research International, 2014:12. |
|
|
Chemegni BC, Mbamzock EKO, Sack FN, Ngouadjeu E, Mbanya D (2018). Morbidité et mortalité chez les patients drépanocytaires au service d'hématologie de l'hôpital central de Yaoundé. Health Sciences and Diseases 9(1):71-5. |
|
|
Dagnogo O, Ako AB, Ouattara L, Dago ND, Coulibaly DNG, Touré AO, Djaman JA (2018). Towards a re-emergence of chloroquine sensitivity in Côte d'Ivoire? Malaria Journal 17(1):413. |
|
|
David TJN, Sylvain B, Brice B, William Y, Joseph DA (2013). In vitro susceptibility of 57 isolates of plasmodium falciparum to atovaquone and lumefantrine in Abidjan. International Journal of Biotechnology 2(9):154-162. |
|
|
David TJN, William Y, Dominique TK, Monsan C, Felix YH, Joseph, DA (2014). In vitro susceptibility of plasmodium falciparum to luméfantrine and analysis of polymophysims in pfmdr-1 gene isolates from Abidjan (Côte d'Ivoire). International Journal of Pharmaceutical Sciences and Research 5(5):1732-1738. |
|
|
Désiré AMH, Félicité D, Suzanne NU, Vanessa MF, Anasthasie AY, Nlend NEA, Ndombo KOP, Tchokoteu PF (2017). Aspects Épidémiologiques , Cliniques et Thérapeutiques des Crises Vaso- Occlusives chez les Enfants Drépanocytaires en Milieu Hospitalier à Yaoundé Epidemiological , clinical and therapeutic aspects related to the occurrence of vaso - occlusive crises in. Health Sciences and Diseases 18(4):89-97. |
|
|
Djaman JA, Olefongo D, Ako AB, Roman J, Ngane VF, Basco LK, Tahar R (2017). Molecular epidemiology of malaria in Cameroon and Côte d'Ivoire. XXXI. Kelch 13 propeller sequences in plasmodium falciparum isolates before and after implementation of artemisinin-based combination therapy. The American Journal of Tropical Medicine and Hygiene 97(1):222-224. |
|
|
Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, White NJ (2010). Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): An open-label, randomised trial. The Lancet 376(9753):1647-1657. |
|
|
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, White NJ (2009). Artemisinin Resistance in Plasmodium falciparum Malaria. The New England Journal of Medicine 361(5):455-467. |
|
|
Ferdig MT, Cooper RA, Mu J, Deng B, Joy DA, Su XZ, Wellems TE (2004). Dissecting the loci of low-level quinine resistance in malaria parasites. Molecular Microbiology 52(4):985-997. |
|
|
Gadalla NB, Elzaki SE, Mukhtar E, Warhurst DC, El-Sayed B, Sutherland CJ (2010). Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum. Malaria Journal 9(1):74. |
|
|
Gupta SK, Singla LD (2012). Diagnostic trends in parasitic diseases of animals. In: Veterinary Diagnostics: Current Trends. Gupta RP, Garg SR, Nehra V and Lather D (Eds), Satish Serial Publishing House, Delhi pp. 81-112. |
|
|
Huang B, Deng C, Yang T, Xue L, Wang Q, Huang S, Su XZ, Liu Y, Zheng S, Guan Y, Xu Q, Zhou J, Yuan J, Bacar A, Abdallah KS, Attoumane R, Mliva AMSA, Zhong Y, Lu F, Song J (2015). Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy. Parasites & Vectors 8(1):634. |
|
|
Ikeda M, Kaneko M, Tachibana SI, Balikagala B, Sakurai-Yatsushiro M, Yatsushiro S, Takahashi N, Yamauchi M, Sekihara M, Hashimoto M, Katuro OT, Olia A, Obwoya PS, Auma MA, Anywar DA, Odongo-aginya EI, Okello-onen J, Hirai M, Ohashi J, Mita T (2018). Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016. Emerging Infectious Diseases 24(4):718-726. |
|
|
Komba AN, Makani J, Sadarangani M, Ajala?Agbo T, Berkley JA, Newton CRJC, Marsh K, Williams, TN (2009). Malaria as a Cause of Morbidity and Mortality in Children with Homozygous Sickle Cell Disease on the Coast of Kenya. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 49(2):216-222. |
|
|
Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimdé AA, Kouriba B, Taylor TE, Plowe CV (2003). Reemergence of Chloroquine?Sensitive Plasmodium falciparum Malaria after Cessation of Chloroquine Use in Malawi. The Journal of Infectious Diseases 187(12):1870-1875. |
|
|
Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Aye MM, Lindegardh N, Tarning J, Imwong M, Jacob CG, Rasmussen C, Perin J, Ringwald P, Nyunt MM (2013). Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar. PloS One 8(3):e57689. |
|
|
Lainé A, Diallo D, Traoré B (2012). De Koloci à la drépanocytose. Anthropologie et Santé 4 p. |
|
|
Laufe MK, Plowe CV (2004). Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies. Drug Resist Updat 7(4-5):279-288. |
|
|
Le Bras J, Ringwald P (1990). Plasmodium falciparum chemoresistance. The situation in Africa in 1989. Medecine Tropicale: Revue Du Corps de Sante Colonial 50(1):16. |
|
|
Le Nagard H, Vincent C, Mentré F, Le Bras J (2011). Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Computer Methods and Programs in Biomedicine 104(1):10-18. |
|
|
Makani J, Komba AN, Cox SE, Oruo J, Mwamtemi K, Kitundu J, Magesa P, Rwezaula S, Meda E, Mgaya J, Pallangyo K, Okiro E, Muturi D, Newton CR, Fegan G, Marsh K, Williams TN (2010). Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood 115(2):215-220. |
|
|
Menard S, Tchoufack JN, Maffo CN, Nsango SE, Iriart X, Abate L, Tsapi MT, Awono-Ambéné PH, Abega-Mekongo FA, Morlais I, Berry A (2016). Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates. Malaria Journal 15(1):572. |
|
|
Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, MacKinnon M, Nzila A (2009). Chloroquine resistance before and after its withdrawal in Kenya. Malaria Journal 8(1):106. |
|
|
Naumann KM, Jones GL, Saul A, Ross S (1992). Parasite-induced changes to localized erythrocyte membrane deformability in Plasmodium falciparum cultures. Article in Immunology and Cell Biology 70(4):267?275. |
|
|
Ndam NT, Basco LK, Ngane VF, Ayouba A, Ngolle EM, Deloron P, Peeters M, Tahar R (2017). Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon. Malaria Journal 16(1):1-6. |
|
|
Ndiaye M, Faye B, Tine R, Ndiaye JL, Lo A, Abiola A, Dieng Y, Ndiaye D, Hallett R, Alifrangis M, Gaye O (2012). Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal. The American Journal of Tropical Medicine and Hygiene 87(4):640-645. |
|
|
Nebor D, Bowers A, Hardy-Dessources MD, Knight-Madden J, Romana M, Reid H, Barthélémy JC, Cumming V, Hue O, Elion J, Reid M, Connes P, Study C (2011). Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation. Haematologica 96(11):1589-1594. |
|
|
Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM (2008). Evidence of artemisinin-resistant malaria in Western Cambodia. In New England Journal of Medicine 359(24):2619-2620. |
|
|
Oniyangi O, Omari AA (2019). Malaria chemoprophylaxis in sickle cell disease. Cochrane Database of Systematic Reviews 3:1?18. |
|
|
Ord R, Alexander N, Dunyo S, Hallett R, Jawara M, Targett G (2007). Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. The Journal of infectious diseases 196(11):1613-1619. |
|
|
Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN (2013). Global Burden of Sickle Cell Anaemia in Children under Five, 2010-2050: Modelling Based on Demographics, Excess Mortality, and Interventions. PLoS Medicine 10(7):e1001484. |
|
|
Piel FB, Steinberg MH, Rees DC (2017). Sickle Cell Disease. The New England Journal of Medicine 376(16):1561-1573. |
|
|
Pradines B, Rogier C, Fusai T, Tall A, Trape JF, Doury JC (1998). In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. The American Journal of Tropical Medicine and Hygiene 58(3):354-357. |
|
|
Sawadogo D, Tolo-Dilkébié A, Sangaré M, Aguéhoundé N, Kassi H, Latte T (2014). Influence of the clinical status on stress reticulocytes, CD 36 and CD 49d of SSFA2 homozygous sickle cell followed in Abidjan. Advances in hematology 2014:1?6. |
|
|
Serge-Brice A, André TO, Lacinan O, Kalou DZ, Carine JAY, Marie-Ange JKK, Ali SY, Kouadio NL, Yalamoussa C, Seka DA, Koffi DA (2020). Efficacy and safety of Artemether-Lumefantrine and Artesunate-Amodiaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Northern Côte d'Ivoire. African Journal of Parasitology Research 7(12):1-011. |
|
|
Sonia D, Kisito N, Laure T, Ismaël T, Madibèlè K, Fla K,Diarra Y (2017). Syndromes drépanocytaires majeurs et infections associées chez l'enfant au Burkina Faso. Pan African Medical Journal 26:1?6. |
|
|
Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, Nosten F, Kyaw MP, Nhien NTT, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Plowe CV (2015). Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia. The Journal of Infectious Diseases 211(5):670-679. |
|
|
Takala-Harrison S, Laufer MK (2015). Antimalarial drug resistance in Africa: key lessons for the future. Annals of the New York Academy of Sciences1342(1):62-67. |
|
|
Tolo-Diebkilé A, Koffi KG, Nanho DC, Kouakou B, Sékongo YM,N'Dhatz E, Méité N, Ayémou R, Sawadogo D,Siransy-Bogui L, Sanogo I (2010). Homozygous sickle cell disease in Ivory Coast adults. Cahiers Santé 20(2):63?67. |
|
|
Tossea SK, Adji EG, Coulibaly B, Ako BA, Coulibaly DN, Joly P, Assi SB, Toure A,Jambou R (2018). Cross sectional study on prevalence of sickle cell alleles S and C among patients with mild malaria in Ivory Coast. BioMed Central Research Notes 11:215. |
|
|
Touré AO, Koné LP, Jambou R, Konán TD, Derriba S, Beugre GE, Koné M (2008). Sensibilité in vitro de falciparum à la quinine, l'artésunate et la chloroquine à Abidjan (Côte d'Ivoire). Cahiers Sante 18(1):43-47. |
|
|
Toure OA, Assi SB, Kiki-Barro PMC, Yavo W, Abba T, Tiacoh LN, Konate AA, Angora EK, Bedia VA, Menan H, Daho AK, Emmanuel B (2020). Efficacy and safety of artesuante-amodiaquine and artemether lumefantrine, the first line malaria treatment in six sentinel's sites of Côte d'Ivoire, West Africa. Annals of Parasitology, 66(4):561-571. |
|
|
Toure O, Landry N, Valerie I, Brice A, Emmanuel K, Adonis K, Stephane Y, Eric A, Viviane KL, Gbessi A, Sylvain B, Karil T, Berenger A, Albert G, Joseph D (2018). Current Efficacy of the First Line Uncomplicated Malaria Treatment in Two Sentinels Sites of Côte d'Ivoire. International Journal of Clinical Research & Trials 3(1):124. |
|
|
Wang J, Huang Y, Zhao Y, Ye R, Zhang D, Pan W (2018) Introduction of F446I mutation in the K13 propeller gene leads to increased ring survival rates in Plasmodium falciparum isolates. Malaria Journal 17(1):1-9. |
|
|
Wang Z, Wang Y, Cabrera M, Zhang Y, Gupta B, Wu Y, Kemirembe K, Hu Y, Liang X, Brashear A, Shrestha S, Li X, Miao J, Sun X, Yang Z, Cui L (2015). Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller gene. Antimicrobial Agents and Chemotherapy 59(11):6952-6959. |
|
|
World Health Organization (WHO) (2019). World malaria report 2019. |
|
|
Wiley JS, McCulloch KE (1982). Calcium ions, drug action and the red cell membrane. Pharmacology and Therapeutics in Dentistry 18(2):271-292. |
|
|
Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, Lim P, Mao S, Sopha C, Sam B, Anderson JM, Duong S, Chuor CM, Taylor WRJ, Suon S, Mercereau-Puijalon O, Fairhurst RM, Menard D (2013). Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. The Lancet Infectious Diseases 13(12):1043-1049. |
|
|
Yamaja SBN, Kulkarni S, Stuart MJ (2002). Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood 99(5):1564-1571. |
|
|
Yavo W, Bla KB, Djaman AJ, Assi SB, Basco LK, Mazabraud A, Koné M (2010). In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire). African Health Sciences 10(2):111-116 |
|
|
Yavo W, Konaté A, Kassi FK, Djohan V, Angora EK, Kiki-Barro PC, Vanga-Bosson H, Menan EIH (2015). Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire. Malaria Research and Treatment 2015:1-8. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
